Olympus : Notification for the Candidate for the Board of Directors

1

February 4, 2022

News Release

Company: Olympus Corporation

Yasuo Takeuchi, Director, Representative Executive Officer, President and CEO

(Code: 7733, First Section, Tokyo Stock Exchange)

Contact: Takaaki Sakurai, Vice President, Investor Relations

TEL: [phone]

Notification for the Candidate for the Board of Directors

Pursuant to the resolution of the Nominating Committee today, Olympus Corporation ("Olympus") announces the changes in the member of the Board of Directors as set out below. The appointments of Directors are subject to the approval of the General meeting of Shareholders scheduled to be held in June 2022.

1. Changes in the Board of Directors

1. New Director

Outside Director	Yasushi Shingai
Outside Director	Kohei Kan
Outside Director	Gary John Pruden
(2) Retiring Directors
Outside Director	Susumu Kaminaga
Outside Director	Atsushi Iwasaki

2. Profile of Candidates for New Director Yasushi Shingai

Date of birth:	January 11, 1956
Profiles:	April 1980	Joined Japan Tobacco and Salt Public Corporation (currently Japan
		Tobacco Inc.)
	June 2004	Executive Officer and Finance Group Leader, Japan Tobacco Inc.
	July 2004	Executive Officer and Senior Vice President, CFO, Japan Tobacco
		Inc.
	June 2005	Director, Executive Officer and Senior Vice President, CFO, Japan
		Tobacco Inc.
	June 2006	Director, Japan Tobacco Inc.
		Executive Vice President and Deputy CEO, JT international S.A.
	June 2011	Representative Director, Executive Vice President and Deputy
		CEO, Japan Tobacco Inc.
	June 2014	Outside Director, Recruit Holdings Co., Ltd.

January 2018	Director, Japan Tobacco Inc.
March 2018	Outside Director, Asahi Group Holdings, Inc.(Present)
June 2018	Outside Director, Exa Wizards Inc. (Present)
June 2018	Outside Director, Mitsubishi UFJ Financial Group, Inc. (Present)
June 2019	Outside Director, Dai-ichi Life Holdings, Inc. (Present)
June 2021	Outside Director, Nippon Telegraph and Telephone West
	Corporation (Present)

Reasons	for	Mr. Yasushi Shingai served as Director, Executive Officer and Senior Vice President, CFO
selection	as	of Japan Tobacco Inc., Executive Vice President and Deputy CEO of JT International S.A.
a candidate:	and Representative Director, Executive Vice President and Deputy CEO of Japan Tobacco
		Inc. He has extensive experience as top management position of a global company and
		possesses not only corporate finance, but also knowledge in the acquisition of global

companies, management and governance after the acquisition. He also has experience as an Outside Director at several other companies. Based on the above, we have determined that Mr. Shingai will contribute to the sustainable growth of Olympus and the increase of corporate value over the medium to long term, Accordingly, we have nominated him as a candidate for an outside director.

Kohei Kan
Date of birth:	March 7, 1960
Profiles:	September 1986	Registered as Certificated Public Accountant
	April 1987	Joined Mita Audit Corporation (currently Deloitte Touche
		Tohmatsu LLC)
	June 1998	Partner, Deloitte Touche Tohmatsu LLC
	November 2013	Board Member, Deloitte Tohmatsu Group and Deloitte Touche
		Tohmatsu LLC
	November 2015	Chief Executive Officer, Deloitte Touche Tohmatsu LLC
	June 2018	Senior advisor, Deloitte Tohmatsu LLC
	September 2018	Audit & Assurance Leader, Deloitte Asia Pacific Limited
	January 2020	Senior Advisor, Deloitte Asia Pacific Limited
	October 2020	Director, Kan Kohei Certified Public Accountant Office (present)
	November 2020	Board Member, International Federation of Accountants "IFAC"
		(present)

Reasons	for	Mr. Kohei Kan has his abundant experience and extensive knowledge as a Certified Public
selection	as	Accountant, in addition, Mr. Kan has experience working as a comprehensive
a candidate:	representative of Deloitte Touche Tohmatsu LLC in auditing many companies,
		2

strengthening governance and risk management that contributes to the sustainable growth of companies. He also has experience in working in Italy and the United States, as well as in auditing and assurance businesses in the Asia-Pacific region with a global perspective. In addition, he is currently assuming a board member of the International Federation of Accountants. Based on the above, we have determined that Mr. Kan will contribute to the sustainable growth of Olympus and the increase of corporate value over the medium to long term. Accordingly, we have nominated him as a candidate for an Outside Director.

Although he has not been involved in corporate management in the past, it is judged that he can perform his duties as an outside director appropriately for the above-mentioned reasons.

Gary John Pruden
Date of birth: May 10, 1961
Profiles:	October 1985	Joined Janssen Pharmaceutica
	June 1999	Director of Marketing, GI Franchise Marketing, Janssen
		Pharmaceutica
	May 2001	Vice President, Marketing, Primary Care Franchise, Janssen
		Pharmaceutica
	November 2002	Vice President, Marketing, CNS Franchise, Janssen Pharmaceutica
	February 2004	President & Chief Operating Officer, Janssen-Ortho INC
	January 2009	Worldwide President, Ethicon Inc
	April 2009	Company Group Chairman, Ethicon Inc
	January 2012	Worldwide Chairman, Global Surgery Group, Johnson & Johnson
	June 2015	Executive Vice President & Worldwide Chairman, Medical
		Devices, Johnson & Johnson
	December 2017	Independent Board Director, Motus GI (present)
	April 2018	Independent Board Director, Lantheus Holdings Inc (present)
	December 2019	Chief Executive Officer, GPS Med Tech Strategy Consulting
		(present)

Reasons	for	Mr. Gary John Pruden has over 30 years of global business experience and extensive
selection	as	experience and knowledge as a top management at Johnson & Johnson, one of the world's
a candidate:	leading companies in the healthcare industry. He also has experience as an outside director
		of several U.S. companies. Based on the above, we have determined that he will contribute
		to the sustainable growth of Olympus and the increase of corporate value over the medium
		to long term, as well as enhancing the internationality and diversity of the Board of

Directors as a global medtech company, which we are aiming for. Accordingly, we have nominated him as a candidate for an outside director.

3

3. Candidate for Directors (Subject to the approval of the General meeting of Shareholders）

Director, Representative Executive Officer	Yasuo Takeuchi	Reappointment
Outside Director	Sumitaka Fujita	Reappointment
Outside Director	Tetsuo Iwamura	Reappointment
Outside Director	Yasumasa Masuda	Reappointment
Outside Director	D. Robert Hale	Reappointment
Outside Director	Jimmy C. Beasley	Reappointment
Outside Director	Sachiko Ichikawa	Reappointment
Outside Director	Yasushi Shingai	New Appointment
Outside Director	Kohei Kan	New Appointment
Outside Director	Gary John Pruden	New Appointment
Director, Executive Officer	Stefan Kaufmann	Reappointment
Director	Nobuyuki Koga	Reappointment

4. (Appendix) Formation of Executive Officers

Olympus decided on the appointment of its Executive Officers from April 1, 2022 as follows. The appointment was originally announced in the timely disclosure "Notification with new appointment of the Executive Officers" dated September 24, 2021. It is scheduled to be decided formally in the Board of Directors at the end of March

2022.
Executive Officer and	Yasuo Takeuchi	Reappointment
Chief Executive Officer
Executive Officer and	Nacho Abia	Reappointment
Chief Operating Officer
Executive Officer and	André Rogan	New Appointment
Chief Technology Officer
Executive Officer and	Tetsuo Kobayashi	New Appointment
Chief Manufacturing and Supply Officer
Executive Officer and	Chikashi Takeda	Reappointment
Chief Financial Officer
Executive Officer and	Stefan Kaufmann	Reappointment
Chief Administrative Officer

4